Frías SJA, Hernández DS, Molina MFJ, García AMG

Language: Spanish
References: 45
Page:
PDF size: 52.28 Kb.

ABSTRACT

The shigellosis is acute infection digestive tract cause by Shigella sp . Is uncommon among HIV seropositive patients and may be complicated in some with bacteremia in the 4%the patients graves, associated mortality 20%; S. flexneri being the most frequently detected Serogroup. The sepsis is diagnosed immunocompromised. We report here an HIV patient with Shigella bacteremia

REFERENCES

1. Farmer J, Kelly M. Enterobacteriaceae. Balows AW, Hauster K, Hermann H. Manual of Clinical Microbiology 5th Ed. AMS Washington DC 1990.

2. Grasnick A. Processing and interpretation of fecal cultures . Ed Isenberg HD. Clinical Microbiology Procedures handbook. American Microbiology Society Washington DC 1992: 1. 10. 1-25.

3. Admoni O, Yagupsky P, Golan A y cols. Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel. Scand J Infect Dis 1995; 27: 139-144.

4. Dupont HL. Shigella species (bacillary dysentery) . En: Mandell GL, Douglas RG, Bennett JE (eds) . Principles and practice of infectious diseases . 3a ed. Nueva York, John Wiley, 1990; 1. 716-1. 722.

5. Halpern Z, Dan M, Giladi M, Schwartz I, Sela O, Levo I. Infecciones por Shigella. Shigellosis in adults: Epidemiologic, clinical and laboratory features. Medicine (Baltimore) 1989; 68: 210-227.

6. Lima AA, Lima NL. E pidemiology, therapy and prevention of infection with Shigella organisms and Clostridium difficile . Curr Opin Infect Dis 1993; 6: 63-71.

7. Baskin DH. Shigella bacteremia in patients with the acquired immunodeficiency Syndrome . Am J Gastroenterol 1987; 82: 338-341.

8. Mathan VI, Mathan MM. Intestinal manifestations of invasive diarrheas and their diagnosis . Rev Infect Dis 1991; 13 (suppl 4) : S311-313.

9. Mirelis B, Portus M, Rabella N, Coll P, Ausina V, Prats G. Estudio etiológico de la gastroenteritis en un hospital universitario durante1983 . Enferm Infecc Microbiol Clin 1986; 4: 30-38.

10. Prats G, Gurgui M, Mirelis B, Ausina V, Nebot J. Disentería autóctona por S. boydii. Enferm Infecc Microbiol Clin 1985; 4: 14-16.

11. Taelman H, Ruginbanaya H, Taelman H y cols. Case –control etiological study of chronic diarrhea among HIV infected adults in Rwanda . 12TH World AIDS conference Geneva jun28-july 3 1998; Abs. 32105.

12. Kristjansson M, Viner B, Maslow JN. P olymicrobial and recurrent bacteremia with Shigella in a patient with AIDS . Scand J Infect Dis 1994; 26: 411-416.

13. Morduchowicz G, Huminer D, Siegman IY, Drucker M, Block CS, Pitlik SD. Shigella bacteremia in adults. Arch Intern Med 1987; 147: 2034-2037.

14. Barret CE, Connors DG. Extraintestinal manifestations of shigellosis . Am J Gastroenterol 1970; 53: 234-245.

15. Jackson HP, Kilgore DG. Purulent meningitis caused by Shigella flexneri. SC Med Assoc J 1971; 67: 347-350.

16. Struelens MJ, Patte D, Kabir I y cols. Shigella septicemia: Prevalence, presentation, risk factors, outcome. J Infect Dis 1985; 152: 784-7900.

17. Graber CD, Browning D, Davis JS. Shigellemia without Shigella diarrhea. Report of a case. Am J Clin Pathol 1966; 46: 21-24.

18. Kazal HL, Sohn N, Carrasco JI. The gay bowel syndrome: Clinico pathologic correlation in 260 cases. Ann Clin Lab Sci 1976; 6: 184-192.

19. Mandell W, Neu HC. Shigella bacteremia in adults . JAMA 1986; 255: 3116-7.

20. Anaya BF, Pérez RMJ, Giralt MP, Romero AMD. Infección del tracto urinario por Shigella sonnie. An Pediatr 2003: 58: 614.

21. Keusch GT. Shigella infections . Clin Gastroenterol 1979; 8: 645-662.

22. Rangel FMS, Pittet D, Costigan MH, Wang T, Davis CD, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS) . A prospective study. JAMA 1995; 273: 117-123.

23. Rangel FMS. Epidemiología de la sepsis bacteriana . Enf Infec Microbiol 1999; 19: 173-180.

24. Bone RC. The sepsis syndrome. Definition and general approach to Management. Clin Chest Med 1996; 17: 175.

25. Badley AD, Steckerlberg JM. Síndrome de sepsis en: Diagnóstico y Tratamiento de enfermedades infecciosas . Wilson WR, Ed. Manual Moderno México, DF; 1a Ed español. 2003: 265-274.

26. Torres TM. Canueto J, Bascunana A y cols. Prognostic evaluation of Bacteremia and fungemia in patients with acquired immunodeficiency Syndrome . Eur J Clin Microbiol Infect Dis 2002; 2: 262-268.

27. Bonadio M. Gigli C. Maccanti O. Longo B. Smorfa A. Bloodstream infections in HIV-positive patients: a review of sixtyeight episodes . J Chemotherapy 1998; 10: 243-247.

28. Wisplinghoff H, Bischoff T, Seifert H, Wenzel RP, Edmond MB. Systemic Inflammatory response in patients with nosocomial bloodstream infections due to Candida sp. K-770. 43rd. ICAAC, Chicago Ill USA. Sep. 14-17, 2003.

29. Esparza M, Lozano LI. Factores asociados a mortalidad en choque séptico en una unidad d terapia intensiva pediátrica. B-129. Resúmenes de XXVI Congreso de la Asociación Mexicana de Infectología y Microbiología Clínica, Enfermedades Infeccionas y Microbiología Méx. 2001; 21S: S51.

30. Levi I, Barzilai A, Rubinowitz B, Ben David B, Keller N, Rubenstein B. Bacteremia in patients AIDS Israeli. 12TH World AIDS conference Geneva Jun 28-July 3 1998; Abs. 60800.

31. Kamya MR, Ssaly SN, Waberi MN y cols. Community acquired bacteremia and mycobacteremia in febrile adults admitted to Mulago hospital in Kampala Uganda . 12TH World AIDS conference Geneva Jun 28-July 3 1998; Abs. 22109.

32. Mutshelckhausen EJ, Leen M, Emmanuel X y cols. Community acquired bacteremia in HIV infected patients. 12TH World AIDS conference Geneva Jun28-july 3 1998; Abs. 22110.

33. Sappington WFP, Alexis LC, Delapenha LA, McNeil JI, Gram negative bacteremia in HIV infected patients: microbiology, risks factors and outcome . 12TH World AIDS conference Geneva Jun 28-July 3 1998; Abs. 22118.

34. Coma EP, Domingo MA, Baraldes JM, Guardiola F, Madrid J, Lopes JM. A prospective study of non mycobacterial bacteremia in HIV infected patients. 12TH World AIDS conference Geneva Jun 28-July 3 1998; Abs. 60322.

35. Salas CB, Cruz RJC, Monte BRJ, Bravo FL. Septicemia por Shigella. Presentación de casos y revisión de la literatura. Rev Cubana Med Trop 1995; julio – diciembre 1995.

36. Greenberg D, Shai M, Rimma M, Matityahu L. Shigella bacteremia: A retrospective study . Clin Pediatr 2003; 42: 411- 415.

37. Huebner J, Czerwenka W, Gruner E, von Graevenitz A. Shigellemia in AIDS patients: case report and review of the literature . Infection 1993; 21: 122-124.

38. Kruse H, Kariuki S, Soli N, Olsvok O. Multiresistant Shigella species from African AIDS patients: antibacterial resistance patterns and application of the E Test for determination of minimum inhibitory concentration. Scand J Infect Dis 1992; 24: 733-739.

39. Herrera ML, Moya T, Duarte I, Guevara J, Bogantes A. Septicemia por Shigella flexneri. Rev Med Hosp Nac Niños (Costa Rica) 1996; 31: 1-2.

40. Banish ML, Salam MH, Khan WA, Khan AM. Treatment of Shigellosis: III comparison of one or two-dose ciprofloxacin with standard day therapy . Ann Intern Med 1992; 117: 727-734.

41. Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991; 13 (suppl 4) : S332-341.

42. Wiström J, Jertborn M, Ekwall E, Norlin K et al. Empiric treatment of acute diarrhea disease with norfloxacin . Ann Intern Med 1992; 117: 202-208.

43. Galera C, Redondo C, Poza G, Pérez D, Cano A. Survival in HIV infected patients after their first episode bacteremia . 13ta International AIDS Conference Durban SA 9-14 July 2000; Abs. TuPeC3313.

44. Andres PA, Petroni D, Faccone D y cols. Extended spectrum cephalosporin Resistance in Shigella flexneri from Argentina: The first report of TOHO-1outside Japan . 44th ICAAC Washington DC Oct 30 –Nov 2, 2004. Abs C2-1325.

45. Elsayed S, Kuhn SM. Antimicrobial susceptibilities of Shigella sp isolated in Calgary, Canada: a 4 year review . 44th ICAAC Washington DC Oct 30 – Nov 2, , 2004. Abs C2-1722.